{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:14:19Z","timestamp":1791036859611,"version":"4.1.0"},"reference-count":14,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid0912.030178","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T18:17:53Z","timestamp":1337105873000},"page":"1617-1620","source":"Crossref","is-referenced-by-count":53,"title":["Visceral Leishmaniasis Treatment, Italy"],"prefix":"10.3201","volume":"9","author":[{"given":"Luigi","family":"Gradoni","sequence":"first","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Gramiccia","sequence":"additional","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Scalone","sequence":"additional","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2003,12]]},"reference":[{"key":"key-10.3201\/eid0912.030178-201205150400-R1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","article-title":"The increase in risk factors for leishmaniasis worldwide.","volume":"95","author":"Desjeux","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.3201\/eid0912.030178-201205150400-R2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0035-9203(87)90314-2","article-title":"Visceral leishmaniasis of adults in Sicily: a truce interrupted?","volume":"81","author":"Mansueto","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.3201\/eid0912.030178-201205150400-R3","unstructured":"Gradoni L. Epizootiology of canine leishmaniasis in southern Europe. In: R. Killick-Kendrick, editor. Canine leishmaniasis: an update. Proceedings of the Canine Leishmaniasis Forum, Barcelona, Spain. Wiesbaden, Germany: Hoechst Roussel Vet; 1999. p. 32\u20139."},{"key":"key-10.3201\/eid0912.030178-201205150400-R4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/00002030-199606001-00014","article-title":"Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy.","volume":"10","author":"Gradoni","year":"1996","journal-title":"AIDS"},{"key":"key-10.3201\/eid0912.030178-201205150400-R5","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1086\/344325","article-title":"Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus.","volume":"186","author":"del Giudice","year":"2002","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid0912.030178-201205150400-R6","first-page":"191","article-title":"Treatment of Mediterranean visceral leishmaniasis.","volume":"73","author":"Gradoni","year":"1995","journal-title":"Bull World Health Organ"},{"key":"key-10.3201\/eid0912.030178-201205150400-R7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/clinids\/22.6.938","article-title":"Short course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome).","volume":"22","author":"Davidson","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid0912.030178-201205150400-R8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/515085","article-title":"Food and Drug Administration approval of AmBisome (lipsomal amphotericin B) for treatment of visceral leishmaniasis.","volume":"28","author":"Meyerhoff","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid0912.030178-201205150400-R9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2165\/00003495-199856060-00005","article-title":"Practical guide for the treatment of leishmaniasis.","volume":"56","author":"Davidson","year":"1998","journal-title":"Drugs"},{"key":"key-10.3201\/eid0912.030178-201205150400-R10","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.","volume":"341","author":"Jha","year":"1999","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid0912.030178-201205150400-R11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4269\/ajtmh.1997.57.75","article-title":"Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy.","volume":"57","author":"Cascio","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid0912.030178-201205150400-R12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00034983.1992.11812717","article-title":"Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.","volume":"86","author":"Gramiccia","year":"1992","journal-title":"Ann Trop Med Parasitol"},{"key":"key-10.3201\/eid0912.030178-201205150400-R13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.41.4.827","article-title":"In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.","volume":"41","author":"Faraut-Gambarelli","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid0912.030178-201205150400-R14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2210-2-11","article-title":"In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.","volume":"2","author":"Carri\u00f3","year":"2002","journal-title":"BMC Pharmacol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/9\/12\/03-0178_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:46:40Z","timestamp":1732589200000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/9\/12\/03-0178_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":14,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2003,12]]}},"URL":"https:\/\/doi.org\/10.3201\/eid0912.030178","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}